Edition:
United States

Arcadia Biosciences Inc (RKDA.OQ)

RKDA.OQ on NASDAQ Stock Exchange Capital Market

16.00USD
24 Apr 2018
Change (% chg)

-- (--)
Prev Close
$16.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
105,176
52-wk High
$66.42
52-wk Low
$3.60

Chart for

About

Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of developmen... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $14.21
Shares Outstanding(Mil.): 42.66
Dividend: --
Yield (%): --

Financials

  RKDA.OQ Industry Sector
P/E (TTM): -- 23.60 356.60
EPS (TTM): -0.41 -- --
ROI: -35.03 2.15 10.64
ROE: -78.63 4.15 13.79

BRIEF-Arcadia Biosciences Files Prospectus Related To Sale Of Up To 2.9 Mln Shares Of Common Stock By Selling Shareholders

* ARCADIA BIOSCIENCES FILES PROSPECTUS RELATED TO SALE OF UP TO 2.9 MILLION SHARES OF COMMON STOCK BY SELLING SHAREHOLDERS - SEC FILING Source text: (https://bit.ly/2uyTUPD) Further company coverage:

Mar 30 2018

BRIEF-Arcadia Biosciences Q4 Loss Per Share $1.39

* ARCADIA BIOSCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

Mar 20 2018

BRIEF-Arcadia Biosciences Welcomes New Chief Commercial Officer

* ARCADIA BIOSCIENCES - SARAH REITER JOINED CO'S EXECUTIVE TEAM AS CHIEF COMMERCIAL OFFICER Source text for Eikon: Further company coverage:

Mar 20 2018

BRIEF-Arcadia Biosciences Announces $10 Mln Private Placement

* ARCADIA BIOSCIENCES ANNOUNCES $10 MILLION PRIVATE PLACEMENT

Mar 19 2018

BRIEF-Arcadia Biosciences announces passing of board chairman George Gosbee

* Arcadia biosciences announces passing of board chairman George Gosbee Source text for Eikon: Further company coverage:

Nov 13 2017

BRIEF-Arcadia Biosciences announces third-quarter financial results

* Arcadia Biosciences announces third-quarter and nine-month 2017 financial results and business highlights

Nov 09 2017

Earnings vs. Estimates